These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28438823)

  • 1. Association of human leukocyte antigen variants and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: A meta-analysis.
    Li X; Zhao Z; Sun SS
    Am J Health Syst Pharm; 2017 May; 74(9):e183-e192. PubMed ID: 28438823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
    Somkrua R; Eickman EE; Saokaew S; Lohitnavy M; Chaiyakunapruk N
    BMC Med Genet; 2011 Sep; 12():118. PubMed ID: 21906289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Ocular Manifestation and Genetic Association of Allopurinol-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in South Korea.
    Lee HS; Ueta M; Kim MK; Seo KY; Sotozono C; Kinoshita S; Yoon KC
    Cornea; 2016 Feb; 35(2):199-204. PubMed ID: 26655481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs.
    Park HJ; Kim YJ; Kim DH; Kim J; Park KH; Park JW; Lee JH
    Yonsei Med J; 2016 Jan; 57(1):118-26. PubMed ID: 26632391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the HLA-B alleles and carbamazepine-induced SJS/TEN: A meta-analysis.
    Wang Q; Sun S; Xie M; Zhao K; Li X; Zhao Z
    Epilepsy Res; 2017 Sep; 135():19-28. PubMed ID: 28618376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.
    Yu KH; Yu CY; Fang YF
    Int J Rheum Dis; 2017 Sep; 20(9):1057-1071. PubMed ID: 28857441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.
    Rashid M; Rajan AK; Chhabra M; Kashyap A; Chandran VP; Venkataraman R; Nair S; Thunga G
    Seizure; 2022 Nov; 102():36-50. PubMed ID: 36183454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.
    Park HJ; Kim SR; Leem DW; Moon IJ; Koh BS; Park KH; Park JW; Lee JH
    Eur J Clin Pharmacol; 2015 Jan; 71(1):35-41. PubMed ID: 25327504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.
    Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP
    Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
    Tohkin M; Kaniwa N; Saito Y; Sugiyama E; Kurose K; Nishikawa J; Hasegawa R; Aihara M; Matsunaga K; Abe M; Furuya H; Takahashi Y; Ikeda H; Muramatsu M; Ueta M; Sotozono C; Kinoshita S; Ikezawa Z;
    Pharmacogenomics J; 2013 Feb; 13(1):60-9. PubMed ID: 21912425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.
    Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK
    Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA-B*1502 allele with lamotrigine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta-analysis.
    Zeng T; Long YS; Min FL; Liao WP; Shi YW
    Int J Dermatol; 2015 Apr; 54(4):488-93. PubMed ID: 25428396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.
    Tangamornsuksan W; Chaiyakunapruk N; Somkrua R; Lohitnavy M; Tassaneeyakul W
    JAMA Dermatol; 2013 Sep; 149(9):1025-32. PubMed ID: 23884208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.
    Hershfield MS; Callaghan JT; Tassaneeyakul W; Mushiroda T; Thorn CF; Klein TE; Lee MT
    Clin Pharmacol Ther; 2013 Feb; 93(2):153-8. PubMed ID: 23232549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
    Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
    Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.
    Gonçalo M; Coutinho I; Teixeira V; Gameiro AR; Brites MM; Nunes R; Martinho A
    Br J Dermatol; 2013 Sep; 169(3):660-5. PubMed ID: 23600531
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Ponzo MG; Miliszewski M; Kirchhof MG; Keown PA; Dutz JP
    J Cutan Med Surg; 2019; 23(6):595-601. PubMed ID: 31378082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Kaniwa N; Saito Y; Aihara M; Matsunaga K; Tohkin M; Kurose K; Sawada J; Furuya H; Takahashi Y; Muramatsu M; Kinoshita S; Abe M; Ikeda H; Kashiwagi M; Song Y; Ueta M; Sotozono C; Ikezawa Z; Hasegawa R;
    Pharmacogenomics; 2008 Nov; 9(11):1617-22. PubMed ID: 19018717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in a Malaysian population.
    Chong HY; Lim YH; Prawjaeng J; Tassaneeyakul W; Mohamed Z; Chaiyakunapruk N
    Pharmacogenet Genomics; 2018 Feb; 28(2):56-67. PubMed ID: 29176400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.